Agenda - Fourth EMA-AESGP bilateral meeting

Fifth European Medicines Agency (EMA) and the Association of the European Self-Medication Industry (AESGP) bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 29 April 2024, 10:00 (CEST) to 29 April 2024, 12:00 (CEST)

Minimum inhibitory concentration (MIC) breakpoints

Psychedelics and their therapeutic use - Linkedin Live interview with Steffen Thirstrup, EMA's Chief Medical Officer, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 7 May 2024, 11:30 (CEST) to 7 May 2024, 12:00 (CEST)

Training and resources for patients and consumers

Human medicines European public assessment report (EPAR): Pramipexole Teva, pramipexole, Date of authorisation: 18/12/2008, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Sivextro, tedizolid phosphate, Date of authorisation: 23/03/2015, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Ontozry, cenobamate, Date of authorisation: 26/03/2021, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Emend, aprepitant, Date of authorisation: 11/11/2003, Revision: 31, Status: Authorised

Emend (aprepitant) supply shortage